Form 8-K   

UNITED STATES  

SECURITIES AND EXCHANGE COMMISSION  

Washington, D.C. 20549  

FORM 8-K  

CURRENT REPORT  

Pursuant to Section 13 or 15(d)  

of the Securities Exchange Act of 1934  

Date of Report (Date of earliest event reported): February 11, 2015  

ALBEMARLE CORPORATION  

(Exact Name of Registrant as Specified in its Charter)  

  [DATA_TABLE_REMOVED] 

451 Florida Street, Baton Rouge, Louisiana 70801  

(Address of Principal Executive Offices, including Zip Code)  

Registrant’s Telephone Number, including Area Code: (225) 388-8011  

Not Applicable  

(Former Name or Former Address, if Changed Since Last Report)  

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:  

   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)  

   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  

   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  

   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))  

 Item 7.01 Regulation FD Disclosure.  

On February 12, 2015, executive officers of Albemarle Corporation (the “Company”) will present at the Morgan Stanley Chemicals Corporate Access Day. The presentation to be used during the conference is attached as Exhibit 99.1 to this Form 8-K. This presentation will also be used during other meetings with investors commencing on February 11, 2015.  

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.  

 Item 9.01. Financial Statements and Exhibits.  

   (d) Exhibits.  

 99.1   Presentation February 12, 2015.  

SIGNATURE  

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.  

  [DATA_TABLE_REMOVED] 

EXHIBIT INDEX  

  Exhibit

Number    Description 

 99.1   Presentation February 12, 2015.